{
  "docId": "019de072-4b47-73db-b658-db74b88c61ed",
  "docSlug": "479ed371379fcba7e292c76acd5b0af7",
  "documentTitle": "BioNTech | Results Presentation Deck | 37 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 37,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "problem_statement",
  "function": "diagnose_problem",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide combines trial design (left) with market/clinical need (right).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-4b47-73db-b658-db74b88c61ed/20",
  "deckHref": "/decks/019de072-4b47-73db-b658-db74b88c61ed",
  "deckJsonHref": "/decks/019de072-4b47-73db-b658-db74b88c61ed.json",
  "deckAnchorHref": "/decks/019de072-4b47-73db-b658-db74b88c61ed#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.42,
        "x": 0.55,
        "y": 0.78
      },
      "kind": "callout",
      "text": "New strategies needed to overcome resistance and maximize efficacy",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34a53944-3876-4032-9726-54405770b191",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.48,
        "x": 0.04,
        "y": 0.215
      },
      "kind": "diagram",
      "text": "Trial design flow from patient selection to 1:1:1 randomization into three treatment arms.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50e7290d-d683-42cc-8bae-60ff02afd2a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.48,
        "x": 0.04,
        "y": 0.65
      },
      "kind": "list",
      "text": "Primary and Secondary Endpoints and Standard of Care Benchmark",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e132b81-e493-44a8-be2b-409a32a7bbb6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.42,
        "x": 0.55,
        "y": 0.215
      },
      "kind": "list",
      "text": "Significant unmet need in R/R NSCLC statistics",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4d3ec3d-a87b-460f-a146-4d1473b39c53",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.04,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "Partnered with Genmab; definitions of abbreviations; citations 1-3.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "109b0de5-4746-4a3d-bd05-43e74cf436fb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "BNT311: Phase 2 Trial Targeting CPI-experienced PD-L1+ R/R NSCLC",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff30f511-96e5-48f2-913a-044cba595301",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}